Middle East and Africa Influenza Vaccines Market 2019-2028

MARKET OUTLOOK

As per an analysis, the influenza vaccines market in the Middle East and Africa is set to surge at a CAGR of 6.18% during the forthcoming years 2019-2028. Saudi Arabia, Turkey, South Africa, the United Arab Emirates and Rest of Middle East & Africa are studied in the Middle East and Africa influenza vaccines market.
The government of Saudi Arabia prioritizes the healthcare segment as a top priority in the country. About $39.2 billion was allocated for the Healthcare and Social Development sector in 2018. It is reported that 22% of this budget will be spent on the Saudi Vision 2030 initiative. In conformity with the government Vision 2030 and the 2020 National Transformation Plan (NTP), the Ministry of Health will spend around $71 billion over five years. These factors are expected to flourish the demand for the influenza vaccines market in the country in the next few years.

In South Africa, influenza is a well-understood disease, causing about 128,000 infections and 11,000 deaths every year. According to a study of South African data during 2013-2015, it is reported that the cost of treating influenza is ZAR 4 billion annually. The country’s healthcare expenditure is about 8.8% of the total GDP, which is considerably higher than in many other developing countries. However, hospital furniture, monitoring equipment and supplies are in shortage, leading to increased cases of medical errors. Hence, the growth potential of the influenza vaccines market in the country is high, when coupled with favorable government policies and public awareness among the public.

COMPETITIVE OUTLOOK

The significant players in the influenza vaccines market are BioDiem, Abbott, Sanofi, CSL Limited and GlaxoSmithKline Plc.

1. Middle East and Africa Influenza Vaccines Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Quadrivalent is the Dominant Type of Influenza Vaccine
2.2.2. Injection is Fastest-Growing Delivery Mode
2.2.3. Cell-Based Technology is Rapidly Growing Technology in the Market
2.2.4. Adult Age Group is Majorly Contributing in the Market
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Intensity of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Advancement in Technology
2.6.2. Initiatives Taken Up by the Government
2.7. Market Restraints
2.7.1. High Cost of Development
2.8. Market Opportunities
2.8.1. Growth in the Cases of Influenza
2.9. Market Challenges
2.9.1. Complex Development Process

3. Influenza Vaccines Market Outlook - by Type

3.1. Quadrivalent Vaccine
3.2. Trivalent Vaccine

4. Influenza Vaccines Market Outlook - by Technology

4.1. Egg-Based Technology
4.2. Cell-Based Technology

5. Influenza Vaccines Market Outlook - by Age Group

5.1. Pediatric Age Group
5.2. Adult Age Group

6. Influenza Vaccines Market Outlook - by Delivery Mode

6.1. Injection
6.2. Nasal Spray

7. Influenza Vaccines Market – Middle East and Africa

7.1. The United Arab Emirates
7.2. Turkey
7.3. Saudi Arabia
7.4. South Africa
7.5. Rest of Middle East & Africa

8. Competitive Landscape

8.1. Merck Sharp & Dohme Corp
8.2. Novartis AG
8.3. Pfizer Inc
8.4. Sanofi
8.5. Biodiem
8.6. Emergent Biosolutions Inc
8.7. F. Hoffmann-La Roche Ltd
8.8. GlaxoSmithKline plc
8.9. Abbott
8.10. CSL Limited

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1: Middle East and Africa Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Middle East and Africa Influenza Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 4: Middle East and Africa Influenza Vaccines Market, by Technology, 2019-2028 (In $ Million)
Table 5: Middle East and Africa Influenza Vaccines Market, by Age Group, 2019-2028 (In $ Million)
Table 6: Middle East and Africa Influenza Vaccines Market, by Delivery Mode, 2019-2028 (In $ Million)
Table 7: Middle East and Africa Influenza Vaccines Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Middle East and Africa Influenza Vaccines Market, by Source, 2019 & 2028 (In %)
Figure 2: Middle East and Africa Quadrivalent Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 3: Middle East and Africa Injection Delivery Model Market, 2019-2028 (In $ Million)
Figure 4: Middle East and Africa Cell Based Technology Market, 2019-2028 (In $ Million)
Figure 5: Middle East and Africa Adult Age Group Market, 2019-2028 (In $ Million)
Figure 6: Porter's Five Force Analysis
Figure 7: Market Attractiveness Index
Figure 8: Middle East and Africa Influenza Vaccines Market, by Quadrivalent Vaccine, 2019-2028 (In $ Million)
Figure 9: Middle East and Africa Influenza Vaccines Market, by Trivalent Vaccines, 2019-2028 (In $ Million)
Figure 10: Middle East and Africa Influenza Vaccines Market, by Egg-Based Technology, 2019-2028 (In $ Million)
Figure 11: Middle East and Africa Influenza Vaccines Market, by Cell-Based Technology, 2019-2028 (In $ Million)
Figure 12: Middle East and Africa Influenza Vaccines Market, by Pediatric Age Group, 2019-2028 (In $ Million)
Figure 13: Middle East and Africa Influenza Vaccines Market, by Adult Age Group, 2019-2028 (In $ Million)
Figure 14: Middle East and Africa Influenza Vaccines Market, by Injection, 2019-2028 (In $ Million)
Figure 15: Middle East and Africa Influenza Vaccines Market, by Nasal Spray, 2019-2028 (In $ Million)
Figure 16: Middle East and Africa Influenza Vaccines Market, Regional Outlook, 2019 & 2028 (In %)
Figure 17: the United Arab Emirates Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 18: Turkey Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 19: Saudi Arabia Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 20: South Africa Influenza Vaccines Market, 2019-2028 (In $ Million)
Figure 21: Rest of Middle East & Africa Influenza Vaccines Market, 2019-2028 (In $ Million)